Find clinical trials for Non-Small-Cell Lung Cancer in Washington, DC
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Small-Cell Lung Cancer trials near Washington, DC, USA:
followed by resection and adjuvant cemiplimab in stage 3 non-small cell lung cancer (NSCLC) with contral...
Phase 2
Washington D.C., District of Columbia, United States and 2 other locations
This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non...
Phase 2
Baltimore, Maryland, United States and 71 other locations
is a multi-center, open label, Phase 1b study of NXP900 in combination with osimertinib in subjects with advanced, progressing, EGFR-mutated non...
Phase 1
Fairfax, Virginia, United States and 2 other locations
type of side effects may occur with the drug treatment. It will also measure the levels of drug in the body and preliminarily assess its anti-cancer...
Phase 1, Phase 2
Fairfax, Virginia, United States and 124 other locations
in participants with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with o...
Phase 3
Bethesda, Maryland, United States and 210 other locations
over time. The third main question is to see if ELVN-002 works to shrink cancers that have HER2 genetic abnormalities, particularly non...
Phase 1
Fairfax, Virginia, United States and 38 other locations
This study is designed to evaluate the antitumor activity of patritumab deruxtecan in participants with metastatic or locally advanced NSCLC with an...
Phase 2
Fairfax, Virginia, United States and 123 other locations
purpose of this study is to evaluate how well Rina-S works against lung cancer.The treatment in this study is Rina-S monotherapy (b...
Phase 2
Fairfax, Virginia, United States and 21 other locations
This is a Phase III, randomized, double-blind, placebo-controlled, multi-center international study assessing the activity of durvalumab and chemothe...
Phase 3
Silver Spring, Maryland, United States and 230 other locations
This is a Phase II, multi-center, open-label platform study evaluating novel combination treatment options in participants with locally advanced or m...
Phase 2
Fairfax, Virginia, United States and 82 other locations
Clinical trials
Research sites
Resources
Legal